The influence of the high-molecular-mass sample matrix in the direct enzymatic measurement of glucose in haemolysate was investigated by a comparison study using ultrafiltered haemolysate for reference. Haemolysate was obtained by 1 : 21 dilution of whole blood with a solution of digitonin and maleinimide. It was shown that at low protein concentration glucose distributes in a 1 : 1 ratio during ultrafiltration. With a hexokinase/glucose-6-phosphate dehydrogenase procedure excellent agreement was found between values measured in haemolysate (y) and ultrafiltrates (x), when incubation was performed at 25 °C (a = 0.047 mmol/1; b = 0.99; r = 0.999, n = 37); at 37 °C, however, the same procedure resulted in a non-tolerable systematic deviation in the direct analysis of haemolysate (a = -0.426 mmol/1; b = 1.00, r = 0.997, n = 37). The precision of measurements in haemolysate and ultrafiltrate was similar (CV 1.0 -1.2%). Since stable reference material with an appropriate matrix is not available, it is important to evaluate haemolysate procedures carefully by comparison studies with patient samples. For reduction of experimental error in such studies we recommend the use of ultrafiltered haemolysate, since this can be analysed side by side with haemolysate in the same run.
Introduction
The hexokinase/glucose-6-phosphate dehydrogenase 1 ) glucose (2) the performance of the hexokinase method principle is the basis for both reference and routine may be compromised by the high-molecular-mass measurement of glucose concentration in body fluids, compounds of the sample matrix, e. g., haemoglobin, In the generally accepted reference measurement pro-erythrocyte phosphogluconate dehydrogenase 1 ) and cedure, protein-free supernatant is used for the anal-glucosephosphate isomerase 1 ) (3). Although it has ysis of serum (1) . Field methods preferably omit de-been shown that good agreement between glucose proteinization for reasons of simplification, but this values obtained from haemolysate and protein-free may be counterbalanced by a loss of accuracy. Es-supernatant is achievable (3 -4) , this has to be conpecially in the direct analysis of haemolysate for blood firmed whenever a relevant analytical variable in the direct glucose measurement is changed, e. g. the type of haemolysing agent, reagent composition, duratioñ , . Ar has already appeared as an abstract (6).
Methods

Reagents and solutions
The reagent kit for glucose determination ("Glucoquant", cat- Before direct analysis or ultrafiltration the spiked matrix material sample was diluted by mixing 1 part with 20 parts of the haemolysing agent containing 50 mg/1 digitonin and 100 mg/1 maleinimide. Individual blood or plasma samples, calibrator solution and control sera were diluted in the same manner.
adaptation of the hexokinase method, which has been used by us for several years for routine measurement, while the 37 °C procedure corresponds to the working scheme given by the reagent manufacturer (ref.
No. 1281-6357-1439) with the exception of slightly lower final dilution of the sample (1 : 546 instead of 1 : 561).
The ΔΑ for the calibrator solution and the unknowns were obtained as the mean of quadruplicate determinations. Glucose concentrations were calculated using spreadsheet software (PlanPerfect Version 5.1, WordPerfect Corporation Orem, Utah, U. S. A.). The between-run CV of single measurements was 1.5 and 1.7% at 25 °C or 1.4 and 2.2% at 37 °C with commercial control sera containing glucose concentrations of 6.3 and 13.1 mmol/1, respectively. The mean values determined by us deviated by -3.0 and -2.0% from the assigned reference method values.
Results
Distribution of glucose during ultrafiltration
The distribution of glucose during ultrafiltration was checked in preliminary investigations. In seven experiments the average recovery of glucose added to glucose-free matrix material (see "Methods") was 100.3 (range: 97.7-102.5) %. After 1 :21 dilution and ultrafiltration of this material at 350 g the mean ratio
Of gluCOSe Concentrations: CdUutedsample/Cultrafiltered sample was 1.004 (range: 0.998-1.017). The glucose concentration in the ultrafiltrate is therefore in close agreement with that of the diluted sample subjected to ultrafiltration.
Stability of indicated absorbance change Figure 1 shows the average glucose concentrations (n = 37) measured at various time points after the , Ώ ,^^^ Ρ " " " " » --f r -" -"Ο start of the reaction using either ultrafiltered or original haemolysate. It can be seen that the relation between the signals (ΔΑ 340 /38ο nm) of ultrafiltered samples and calibrator solution is rather constant for both 25 °C and 37 °C incubation. In the presence of original haemolysate the mean value remains virtually constant at 25 °C, while at 37 °C there is a striking decay of ΔΑ with time.
Influence of the sample matrix on the precision of measurement
The within-run CV calculated from each of 26 measurements of a haemolysate containing 3.7 mmol/1 glucose were 1.1 and 1.0% for incubation temperatures of 25 °C and 37 °C, respectively, while the CV with the corresponding ultrafiltrate was 1.2% (25 °C). Ultrafiltration for deproteinization of samples
The 1 : 21 dilution of blood or plasma with a corresponding decrease of the protein concentration resulted in a much higher filtration rate, compared with the ultrafiltration of undiluted serum or plasma, as used for the measurement of creatinine (8) or ammonia (9). After 1 : 21 dilution of the blood or plasma proteins their volume displacement effect is negligible, and an 1 :1 distribution of glucose during ultrafiltration can be anticipated. This was verified by experiments using matrix material with a known concentra-tion of added glucose (see "Results"). Interestingly a slight underrepresentation of glucose in the ultrafiltrate in the order of 2 -3% was observed in distribution experiments, if the filtration rate was further increased by centrifuging the ultrafilter at 1700 instead of 350 g (data not shown).
The advantage of ultrafiltration with respect to conventional deproteinization with protein precipitating agents is that a dilution and contamination of the sample is avoided (6) . This assures compatibility of the sample with the analytical system used; differences between results from direct analysis and from ultrafiltrate analysis, which exceed the random variation, can be attributed to non-specificity or interference caused by the high-molecular-mass components.
Use of ultrafiltrates for comparison studies
Two variants of an automated procedure for direct measurement of glucose concentration in haemolysate or plasma, differing only with respect to the temperature chosen for incubation (25 or 37 °C), were investigated. The comparison experiments using ultrafiltrates for reference show that at 25 °C there is good agreement between results, while at 37 °C measured values deviate systematically by -0.43 mmol/1 (see tab. 1 and fig. 2 and 3 ). The cause of this negative deviation of results observed at 37 °C in the presence of haemolysate has not been identified; its extent is time dependent (see fig. 1 ). With an alternative hexokinase reagent of different composition inconstant absorbance in direct haemolysate analysis was not observed (10) .
The allowable systematic deviation in the measurement of blood glucose derived from accepted guidelines for statistical quality control (11, 12 ) is 5%, e. g., 0.25 mmol/1 if the expected value is 5 mmol/1. The use of 37 °C for glucose determination in haemolysates with the investigated analytical system would therefore require correction of the results by a constant value. Better still, this incubation temperature should be avoided, because the measurement of glucose should be free of bias (13).
As can be seen from the data in table 1, the agreement of results obtained with diluted plasma and the corresponding ultrafiltrates is also better at 25 than at 37 °C. However, the offset and slope obtained in regression analysis did not differ significantly in the 37 °C procedure from 0 or 1, respectively.
The present study shows that direct analysis of haemolysate using an incubation temperature of 25 °C gives a good analytical performance, which is equivalent to a more laborious variant of the method involving deproteinization. This confirms earlier reports on the use of manual (5) or mechanised techniques (14) at room temperature. On the other hand it should be emphasized that variants of the haemolysate procedure (e.g., with incubation at 37 °C) should be carefully evaluated before they are implemented for clinical service.
Since a suitable stable reference material for quality control is lacking, comparison studies are essential. The use of ultrafiltered samples for reference as described in this paper appears to be a valuable tool in such studies.
